Skip to main content
Skip to main content
Basket
Search
Country

History

Amoena Today

Our mission is to support women’s confidence in leading an active life after breast cancer. More than 400 employees worldwide work to achieve our mission, with 200 team members based in our headquarters in Raubling, Bavaria. With 15 subsidiaries and a comprehensive network of distributors, Amoena is represented in more than 70 countries. We operate around the world, united by the common goal to develop innovative solutions for women diagnosed with breast cancer.

Milestones

history solution
2021

Amoena Solution

With the introduction of our expanded recovery care range, we now offer our customers the Amoena Solution, a full range of items that supports them throughout their breast cancer journey, from diagnosis to returning to their normal daily lives.
History Adapt Air
2019

Adapt Air – the first adjustable breast form

The Adapt Air is unique in that it allows a woman the ability to adjust her form for a personalised fit. The form uses our award-winning air chamber technology and comes with a special easy-to-use pump. A woman may increase or decrease the form to match the shape and volume of her unoperated breast. Perfect for weight fluctuation, lymphoedema or uneven breast development.
2015

Our breast forms get even lighter

Introduction of the Xtra Light prosthesis, which is lighter by approximately 40% compared to a standard breast form of similar size. Women with a larger bust, or who suffer from lymphoedema or neck pain, find lighter breast forms much more comfortable to wear.
2008

COMFORT+ Technology

No more hot, sticky breast forms. Our patented Comfort+ technology regulates the temperature between a woman’s body and her breast form by absorbing excess body heat and releasing it as she cools down. Our technology reduces perspiration behind the breast form for cool, dry comfort all day long.
2004

PORTFOLIO EXPANSION WITH RECOVERY CARE PRODUCTS

The post-surgery care a woman receives affects the outcome of her procedure. Our Recovery Care line was developed specifically for the days and weeks after surgery to provide the best possible support for the healing process from the start.
History Contact
1998

Contact technology

The Amoena Contact breast form adheres directly to the skin, thanks to our special adhesive silicone. Comfortable and secure, it follows the body’s every movement and gives the wearer a unique natural feeling. Easy to put on and take off, the adhesive silicone leaves no trace on the body.
1996

First lightweight breast form

To meet the needs of many women, our first Amoena Lightweight Breast Form is launched. Ideal for women with a larger bust, lymphoedema or neck and shoulder pain, this breast form is 25% lighter than our standard portfolio.
1996

Swimwear is added to our portfolio

Amoena’s breast care range is expanded with the addition of feminine, high-performance post-mastectomy swimwear.
History 1992
1992

Portfolio extension with mastectomy bras

Our first specially designed mastectomy bras, perfectly matched to Amoena breast forms, are launched.
1988

First patent for 2-layer breast forms

With its soft, customisable back, the Nouvelle is our first two-layer breast form with a soft, customisable back.
1978

Internationalisation

Amoena USA Corp., Atlanta is founded. At the end of the 1970s further subsidiaries follow in Great Britain, France, Sweden, Denmark, Spain, Australia, Canada, Poland, Italy, Norway, Belgium, Hong Kong and China.
Gründung
1975

The beginning

Amoena’s journey began with Cornelius Rechenberg. His goal was to find a solution for women after breast cancer surgery that would be far superior to the makeshift bra fillers made of fabric or rubber which were available at the time. With a goal to provide women with a natural feeling and looking breast form, Cornelius was the first to experiment with silicone forms. His pioneering efforts produced the world’s first silicone breast form that set the standard in breast care and continues to be the prototype for the prostheses produced today.